Literature DB >> 31452075

Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.

Shirley V Wang1, Olga V Patterson2,3, Joshua J Gagne4, Jeffrey S Brown5, Robert Ball6, Pall Jonsson7, Adam Wright8, Li Zhou8, Wim Goettsch9,10, Andrew Bate11.   

Abstract

Research that makes secondary use of administrative and clinical healthcare databases is increasingly influential for regulatory, reimbursement, and other healthcare decision-making. Consequently, there are numerous guidance documents on reporting for studies that use 'real-world' data captured in administrative claims and electronic health record (EHR) databases. These guidance documents are intended to improve transparency, reproducibility, and the ability to evaluate validity and relevance of design and analysis decisions. However, existing guidance does not differentiate between structured and unstructured information contained in EHRs, registries, or other healthcare data sources. While unstructured text is convenient and readily interpretable in clinical practice, it can be difficult to use for investigation of causal questions, e.g., comparative effectiveness and safety, until data have been cleaned and algorithms applied to extract relevant information to structured fields for analysis. The goal of this paper is to increase transparency for healthcare decision makers and causal inference researchers by providing general recommendations for reporting on steps taken to make unstructured text-based data usable for comparative effectiveness and safety research. These recommendations are designed to be used as an adjunct for existing reporting guidance. They are intended to provide sufficient context and supporting information for causal inference studies involving use of natural language processing- or machine learning-derived data fields, so that researchers, reviewers, and decision makers can be confident in their ability to evaluate the validity and relevance of derived measures for exposures, inclusion/exclusion criteria, covariates, and outcomes for the causal question of interest.

Mesh:

Year:  2019        PMID: 31452075     DOI: 10.1007/s40264-019-00851-0

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  48 in total

1.  Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

Authors:  S V Wang; P Verpillat; J A Rassen; A Patrick; E M Garry; D B Bartels
Journal:  Clin Pharmacol Ther       Date:  2016-03       Impact factor: 6.875

2.  Graphical Depiction of Longitudinal Study Designs in Health Care Databases.

Authors:  Sebastian Schneeweiss; Jeremy A Rassen; Jeffrey S Brown; Kenneth J Rothman; Laura Happe; Peter Arlett; Gerald Dal Pan; Wim Goettsch; William Murk; Shirley V Wang
Journal:  Ann Intern Med       Date:  2019-03-12       Impact factor: 25.391

3.  Evaluating automated approaches to anaphylaxis case classification using unstructured data from the FDA Sentinel System.

Authors:  Robert Ball; Sengwee Toh; Jamie Nolan; Kevin Haynes; Richard Forshee; Taxiarchis Botsis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-08-28       Impact factor: 2.890

4.  Vaccine adverse event text mining system for extracting features from vaccine safety reports.

Authors:  Taxiarchis Botsis; Thomas Buttolph; Michael D Nguyen; Scott Winiecki; Emily Jane Woo; Robert Ball
Journal:  J Am Med Inform Assoc       Date:  2012-08-25       Impact factor: 4.497

5.  A method and knowledge base for automated inference of patient problems from structured data in an electronic medical record.

Authors:  Adam Wright; Justine Pang; Joshua C Feblowitz; Francine L Maloney; Allison R Wilcox; Harley Z Ramelson; Louise I Schneider; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2011-05-25       Impact factor: 4.497

6.  Drug Regulation and Pricing--Can Regulators Influence Affordability?

Authors:  Hans-Georg Eichler; Hugo Hurts; Karl Broich; Guido Rasi
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

7.  Automated acquisition of disease drug knowledge from biomedical and clinical documents: an initial study.

Authors:  Elizabeth S Chen; George Hripcsak; Hua Xu; Marianthi Markatou; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2007-10-18       Impact factor: 4.497

8.  An end-to-end hybrid algorithm for automated medication discrepancy detection.

Authors:  Qi Li; Stephen Andrew Spooner; Megan Kaiser; Nataline Lingren; Jessica Robbins; Todd Lingren; Huaxiu Tang; Imre Solti; Yizhao Ni
Journal:  BMC Med Inform Decis Mak       Date:  2015-05-06       Impact factor: 2.796

9.  Opportunities and Challenges in Developing a Cohort of Patients with Type 2 Diabetes Mellitus Using Electronic Primary Care Data.

Authors:  Preeti Datta-Nemdharry; Andrew Thomson; Julie Beynon
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

10.  Automated Extraction of VTE Events From Narrative Radiology Reports in Electronic Health Records: A Validation Study.

Authors:  Zhe Tian; Simon Sun; Tewodros Eguale; Christian M Rochefort
Journal:  Med Care       Date:  2017-10       Impact factor: 2.983

View more
  2 in total

1.  Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products.

Authors:  Cynthia J Girman; Mary E Ritchey; Vincent Lo Re
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-05-03       Impact factor: 2.732

2.  Artificial Intelligence, Real-World Automation and the Safety of Medicines.

Authors:  Andrew Bate; Steve F Hobbiger
Journal:  Drug Saf       Date:  2020-10-07       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.